<html>
<head>PUBMED IDs for PBOV1</head>
<body bgcolor='#C5F0F2'><h1>PBOV1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19714462/'>Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.</a> July 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19714461/'>The immunohistochemically &quot;ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative&quot; subgroup is not a surrogate for the normal-like subtype in breast cancer.</a> January 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20804056/'>[Tumor-specific expression of PBOV1, a new gene in evolution].</a> September 10  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23418531/'>PBOV1 is a human de novo gene with tumor-specific expression that is associated with a positive clinical outcome of cancer.</a> August 28  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26549570/'>PBOV1 correlates with progression of ovarian cancer and inhibits proliferation of ovarian cancer cells.</a> October 8  2015<br></body></html>
